...）、非酒精性脂肪性肝炎（Nonalcoholic steatohepatitis，NASH）等非酒精性脂肪性肝脏疾病（Nonalcoholic fatty liver disease，NAFLD）。NAFLD是一类肝组织学改变与酒精性肝病相类似但无过量饮酒史的临床综合征。
基于4个网页-相关网页
...非酒精性脂肪肝 C反应蛋白 【分类号】： R575.5 【正文快照】： 非酒精性脂性肝脏疾病(nonalcoholic fatty liverdisease,NAFLD)的发生与肝细胞中脂肪的长期集聚和肝脏氧化应激作用增强有关[1],后者的直接原因即为胰岛素抵抗(ins...
基于2个网页-相关网页
良性肝脏疾病 benign liver diseases
炎性肝脏疾病 Conductive hearing loss bilateral
遗传性肝脏疾病 Genetic Liver Disease
慢性肝脏疾病量表 Chronic Liver Disease Questionnaire
非酒精性脂性肝脏疾病 NAFLD ; nonalcoholic fatty liver disease
其他炎性肝脏疾病 Other inflammatory liver diseases
未特指的炎性肝脏疾病 Inflammatory liver disease, unspecified
其他特指的炎性肝脏疾病 Other specified inflammatory liver diseases
肝脏囊性疾病 Hepatic cystiform diseases
原发性胆汁淤积性肝硬化(PBC)是一种多发于中年女性、不明原因导致的慢性进行性胆汁淤积性肝脏疾病。
Primary biliary cirrhosis (PBC) is a chronic, progressive cholestatic liver disease of unknown cause that usually affects middle-aged women.
非酒精性脂肪肝是慢性肝脏疾病最常见的原因，估计普通人群患病率为20%-30%，肥胖人群患病率为67%-75%。
NAFLD is the most common cause of chronic liver disease and afflicts an estimated 20%-30% of the general population and 67%-75% of the obese population.
符合条件的患者乙肝表面抗原阳性的代偿性肝脏疾病的男性和女性谁是至少6个月以上的，给予拉米夫定和HBV聚合酶基因突变。
Eligible patients were hepatitis B surface antigen-positive men and women with compensated liver disease who were given lamivudine at least more than 6 months and had HBV polymerase gene mutation.
应用推荐